NOVARTIS PHARMA AG's Net Worth
Estimate Recalculated Nov 7, 2024 04:47PM EST
Who is NOVARTIS PHARMA AG
NOVARTIS PHARMA AG has an estimated net worth of $916 Million. This is based on reported shares across multiple companies, which include REGENERON PHARMACEUTICALS INC, Cellular Biomedicine Group, Inc., Poseida Therapeutics, Inc., ALNYLAM PHARMACEUTICALS, INC., IDENIX PHARMACEUTICALS INC, and PRECISION BIOSCIENCES INC.
SEC CIK
NOVARTIS PHARMA AG's CIK is 0001030617
Past Insider Trading and Trends
2020 was NOVARTIS PHARMA AG's most active year for acquiring shares with 1 total transactions. NOVARTIS PHARMA AG's most active month to acquire stocks was the month of June. 2005 was NOVARTIS PHARMA AG's most active year for disposing of shares, totalling 1 transactions. NOVARTIS PHARMA AG's most active month to dispose stocks was the month of June. 2020 saw NOVARTIS PHARMA AG paying a total of $0.00 for 5,908,089 shares, this is the most they've acquired in one year. In 2014 NOVARTIS PHARMA AG cashed out on 33,320,674 shares for a total of $816,356,513.00, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Form 4 | -100.00% | -7.53M | $11.06 | -$83.25M | Nov 10, 2005 | — | Sale | — | Nov 08 |
Form 3 | — | — | — | — | May 21, 2003 | — | — | — | — |
Cellular Biomedicine Group, Inc.
Form 3 | — | — | — | — | Aug 14, 2020 | 1.46M | — | — | — |
Form 4 | -19.81% | -1.46M | — | — | Jul 16, 2020 | 5.91M | Options | — | Jul 14 |
Form 3 | — | — | — | — | Jul 13, 2020 | — | — | — | — |
Form 4 | -27.70% | -1.55M | $19.42 | -$30.14M | Sep 24, 2012 | 4.05M | Sale | — | Sep 20 |
Form 4 | 1.00% | 55.22K | $17.99 | $993.46K | Apr 26, 2010 | 5.60M | Purchase | — | Apr 23 |
Form 4 | 1.20% | 65.92K | $17.50 | $1.15M | May 06, 2009 | 5.55M | Purchase | — | May 06 |
Form 4 | 4.06% | 213.89K | $25.29 | $5.41M | May 14, 2008 | 5.48M | Purchase | — | May 08 |
Form 3 | — | — | — | — | Oct 24, 2005 | 5.27M | — | — | — |
IDENIX PHARMACEUTICALS INC
Form 4 | -100.00% | -33.32M | $24.50 | -$816.36M | Aug 12, 2014 | — | Disposition | — | Aug 05 |
Form 4 | 0.26% | 84.89K | $3.43 | $291.28K | Feb 23, 2012 | 33.32M | Purchase | — | Feb 23 |
Form 4/A | 0.04% | 26.76K | $3.83 | $114.52K | Dec 09, 2011 | 66.43M | Purchase | — | Nov 22 |
Form 4 | 0.08% | 50.53K | $3.80 | $206.40K | Nov 22, 2011 | 66.44M | Purchase | — | Nov 22 |
Form 4 | 5.69% | 1.79M | $2.80 | $5.00M | Apr 13, 2011 | 33.19M | Purchase | — | Apr 13 |
Form 4 | 0.02% | 20.99K | $3.41 | $55.42K | Feb 25, 2011 | 94.19M | Purchase | — | Feb 25 |
Form 4 | 0.02% | 17.08K | $3.49 | $46.69K | Nov 26, 2010 | 94.13M | Purchase | — | Nov 26 |
Form 4/A | 0.12% | 37.21K | $2.45 | $91.01K | Sep 16, 2010 | 31.36M | Purchase | — | Aug 13 |
Form 4 | 0.04% | 37.21K | $3.08 | $91.01K | Aug 23, 2010 | 94.08M | Purchase | — | Aug 23 |
Form 4 | 0.00% | 1.35K | $2.41 | $3.26K | Jun 08, 2010 | 31.32M | Purchase | — | Jun 08 |
Form 4 | 0.01% | 1.87K | $2.41 | $4.51K | Feb 26, 2010 | 31.32M | Purchase | — | Feb 26 |
Form 4/A | 0.01% | 3.57K | $2.41 | $8.61K | Sep 01, 2009 | 31.32M | Purchase | — | Aug 21 |
Form 4 | 0.01% | 3.43K | $2.41 | $8.27K | Aug 24, 2009 | 31.32M | Purchase | — | Aug 21 |
Form 4 | 0.01% | 2.45K | $2.62 | $6.42K | May 29, 2009 | 31.32M | Purchase | — | May 29 |
Form 4 | 0.02% | 5.44K | $2.41 | $13.12K | Feb 23, 2009 | 31.31M | Purchase | — | Feb 23 |
Form 4 | 0.02% | 4.75K | $4.05 | $19.23K | Nov 25, 2008 | 31.31M | Purchase | — | Nov 19 |
Form 4 | 0.01% | 4.65K | $2.93 | $13.64K | Sep 03, 2008 | 31.30M | Purchase | — | Sep 02 |
Form 4 | 0.00% | 924.00 | $2.41 | $2.23K | May 30, 2008 | 31.30M | Purchase | — | May 29 |
Form 4 | 0.00% | 365.00 | $20.48 | $7.48K | Jun 08, 2006 | 31.30M | Purchase | — | Jun 06 |
Form 4 | 0.01% | 2.94K | $16.23 | $47.68K | Apr 06, 2006 | 31.30M | Purchase | — | Apr 04 |
Form 4 | 14.40% | 3.94M | $20.61 | $81.19M | Nov 02, 2005 | 31.30M | Purchase | — | Oct 31 |
Form 4 | 4.54% | 1.19M | $20.18 | $23.96M | Sep 07, 2005 | 27.36M | Grant | — | Sep 02 |
Form 4 | 13.48% | 6.50M | $14.00 | $75.60M | Jul 28, 2004 | 54.71M | Purchase | — | Jul 27 |
Form 3 | — | — | — | — | Jul 21, 2004 | 20.86M | — | — | — |
Form 3 | — | — | — | — | Jun 27, 2022 | 12.41M | — | — | — |
